| Latest Forum Topics / Enviro-Hub Last:0.026 -- |
|
|
Chasen holdings could be the next big multiplier
|
|||||
|
tonyja
Elite |
06-Jul-2021 23:39
|
||||
|
x 0
x 0 Alert Admin |
Tradeview - Retail Investors Are Not Lambs To Slaughter, They Have Families Too    For many years, our local stock market had subdued retail investors participation. There are many reason why but mainly it has to do with the past financial crises. Whilst writing my book, I did substantial research sifting through past news reports and academic papers. For every cycle between 1987, 1997/98, 2008/09 and 2020, the stock market rally was always precipitated by influx of retail investors pushing it to new highs. However, they are always the last to leave ending up the biggest loser when the market collapse or selloff. This will then cause a period where retail investors participation dwindles to record low before normalising.   This is why brokerage houses or investment bank often focus on institutions / large funds as their key clients. This means they will get good insights from analysts, access to corporate management which help them invest better. Retail investors on the other hand will always be disadvantaged. This caused a vacuum and who fills the void? Fake Gurus   Retail investors influx in 2020 reach levels unseen since the 1993 bull run. Similarly, fake gurus started propping up everywhere. Countless Facebook & Youtube Ads of Fake Gurus flooded my social media. No matter how many times I hide or report ads, just like cockroach, they will find a way to come back. Now imagine, with many new retail investors, this makes them easy target for the Fake Gurus.    Especially in a time of pandemic, where people are locked up at home, businesses are closed, income reduced, job loss, even boredom kicks in. Many invest in stocks hoping to pass time or simply to make ends meet. When those Fake Gurus keep appearing in your screen, showing you his expensive watch, car, house dressed in suit, you start wondering, maybe you should try investing too. With no knowledge in the stock market, your only reliance is the Fake Guru and his " philosophy" . You dont even know whether what he is teaching you is real because the Fake Guru gets celebrity endorsements and pictures with VIPs. When you ask question, they brush you off. You end up blindly following.   Sadly, these bunch of flamboyant and ostentatious people are indeed Fake Gurus who know NOTHING about investments, risk management or valuation. They only know simple theories. Needless to say, tragedy strikes when the market is no longer in a bull run like in 2020. These Fake Gurus had no idea about macroeconomics hence they would not know the intricacies of global landscape, politics or social issues which would necessitate retail investors to conserve cash entering 2021. They would also would not know cashflow importance and missed out Serba Dinamik' s glaring issue. As of today, KLCI is at 1531 which is 9% down from 2020' s peak which is close to a 10% correction.   Why am I writing this? After the FM988 live call suicide incident, I felt very empathetic towards the caller' s predicament. What I didn' t know was there are in fact so many victims like him out there who have paid RM 15k per person to these bunch of Fake Gurus and lost almost everything they invested in the stock market.   Retail investors are crucial towards the healthy development and vibrancy of Malaysia' s stock market. The fact that their record participation in 2020 have filled the void by foreign funds who have been selling our Malaysia stocks for the past 13 consecutive quarters shows how precious they are. If our retail investors are burnt by your actions and never to return to the market, it would lead to a huge void in future just like the Singapore Penny Stock Scandal in 2013.   So, I would like to put this on record, to those Fake Gurus, if you still have conscience and a heart, REFUND every single sen to these poor people. After that, close down your website, social media accounts and do not ever promote yourself as a GURU again. It is not their fault that they are misled by intentional and systemic misrepresentation. They are not lambs for you to slaughter. They have family too.   Full article source : www.tradeview.my |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
06-Jul-2021 07:50
|
||||
|
x 0
x 0 Alert Admin |
Rubber Gloves ASPs to average at US$67-US$75 in second half | Daily Express Online - Sabah' s Leading News Portal![]()   Despite the decline in ASPs, it noted that supply shortage for disposable gloves still remains, with the crunch expected to last until 2023 before supply catches up with demand.   &ldquo With vaccines appearing less effective against certain new variants and upcoming winter towards year-end, we do not rule out the possibility of Covid-19 cases rising again, despite vaccination efforts in key markets. This would inevitably increase the demand for disposable gloves,&rdquo it said in a note Friday. ADVERTISEMENT  The investment bank lowered its financial year 2021/2022 net profit forecasts for Top Glove Corp Bhd by -3.3 per cent/-2.6 per cent, and Kossan Rubber Industries Bhd&rsquo s FY21 net profit forecast by -7.9 per cent to account for lower sales volumes from smaller workforce capacity during full Movement Control Order (FMCO).   The recently imposed FMCO mandates that glove manufacturers operate at 60 per cent workforce capacity from June 1-30 for the duration of the total lockdown.   Furthermore, in the government&rsquo s National Recovery Plan (NRP), Phase Two and Phase Three 3 (July-October 2021) continues to mandate that manufacturers operate at below full capacity (80 per cent workforce). ADVERTISEMENT  At the current price levels, it still expects healthy dividend yields for glove players to support share prices.   At current prices, glove players have FY21/22 dividend yields of 6.9 per cent to 19.2 per cent.   HLIB maintained its &ldquo Overweight&rdquo call on the rubber glove sector and adjusted downwards its target price for Top Glove (RM6.76 to RM6.72) and Kossan (RM5.60 to RM5.54).  |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
tonyja
Elite |
05-Jul-2021 20:41
|
||||
|
x 0
x 0 Alert Admin |
Israel Sees Decline in Pfizer Vaccine Efficacy Rate, Ynet ReportsAlisa Odenheimer5 July 2021, 3:59 PM SGT
The protection conferred by  Pfizer Inc.&rsquo s vaccine against mild forms of Covid-19 appeared to wane after a few weeks in data garnered in Israel as the delta variant took hold, although the shot continued to shield users against severe illness. The vaccine developed with  BioNTech SEprotected 64% of receivers against the illness between June 6 and early July as the government lifted restrictions, down from 94% between May 2 and June 5, the Ynet news website  reported, citing Health Ministry numbers. More importantly, those who were vaccinated remained far less likely to be hospitalized, with protection dropping only slightly to 93% from 98% in the period. The efficacy against serious illness was similar, according to the report. The delta variant, which first emerged in India, is sparking concern as it spreads around the globe, providing a real-life test for vaccines and dashing hopes of recovery in air travel. Dervila Keane, a spokeswoman at Pfizer, declined to comment on the data from Israel but she pointed to  other researchthat shows continued protection against new mutations -- just slightly reduced in some cases. The evidence gathered so far suggests that the vaccine &ldquo will continue to protect against these variants,&rdquo she said. New Curbs?In Israel, where social curbs were lifted at the start of June, many of the new cases are among vaccinated people, according to Ynet. Last Friday, 55% of the newly infected had been vaccinated, the website said. As of July 4, there were 35 serious cases of coronavirus out of a population of 9.3 million, compared with 21 on June 19. The government is considering reinstating additional restrictions after restoring a mandate to wear masks indoors in public spaces. Officials are also discussing whether to recommend a third dose of vaccine, the report said. Pfizer CEO Albert Bourla has  said  people will &ldquo likely&rdquo need a third dose of vaccine within 12 months of getting fully protected. Israel had one of the world&rsquo s most effective coronavirus inoculation drives and some 57% of the population is now fully vaccinated. |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
04-Jul-2021 21:16
|
||||
|
x 0
x 0 Alert Admin |
Malaysian Glove Makers Say Virus Curbs May Hurt Global Supplies 1. Malaysia&rsquo s rubber glove makers appealed to the government to allow factories in Selangor state to still operate amid tighter movement curbs that took effect on Saturday to prevent a disruption in global supplies of the protective gear. 2. The Malaysian Rubber Glove Manufacturers Association is seeking a meeting with the trade ministry as 58% of all gloves produced in the country are sourced from plants in Selangor, Margma President Supramaniam Shanmugam said in a statement on Sunday. 3. The government imposed stricter measures in Selangor, the most industrialized state, and in the capital Kuala Lumpur, which are among Malaysia&rsquo s worst-affected regions despite a nationwide lockdown. Selangor contributed about half the new daily Covid cases on Saturday. 4. &ldquo Global customers of our manufacturers have been calling with great concern on the shortage of production and delivery of gloves to them,&rdquo Shanmugam said. The lockdown had stretched lead times on deliveries and the &ldquo enhanced movement control order will further hamper the supply situation,&rdquo he said. 5. Margma members collectively produce and export gloves to 195 countries, supplying 67% of global consumption. Global demand for medical gloves this year is expected to remain at 420 billion pieces, and jump by 15%-20% in 2022, according to the statement. |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
04-Jul-2021 19:15
|
||||
|
x 0
x 0 Alert Admin |
Avoid glove counter for now  dyodd
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
tonyja
Elite |
04-Jul-2021 19:13
|
||||
|
x 0
x 0 Alert Admin |
---------------------------------------------- Riverstone reply to Malaysia Lockdown: Based on preliminary calculations, taking into account the temporary closures of its manufacturing facilities in Taiping, Perak and limits on workforce capacity to 60% as mandated  by the Malaysian government, the Group has estimated a capacity loss of approximately 200 million pieces of gloves, or approximately a 2% impact on the Group& rsquo s total annual  production capacity of 10.5 billion pieces. ------------------------------------------------ |
||||
| Useful To Me Not Useful To Me | |||||
|
Boscoyes
Member |
04-Jul-2021 18:09
|
||||
|
x 0
x 0 Alert Admin |
Wow so long this post....can conclude buy or no buy?☺ ️
|
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
04-Jul-2021 15:18
|
||||
|
x 0
x 0 Alert Admin |
The Stock Market Has Its Own Dark SideTradeviewSunday, 04 July 2021
![]()   Recently, I was shown a video clip on Facebook where a retail investor who suffered major losses in the stock market contemplating suicide and called up DJ Chan Fong of FM 988 seeking for advice. (For full video please go to DJ Chan Fong 988 facebook link  HERE  )  Briefly, prior to Covid-19, he was working in the tourism sector but lost his income stream, so he decided to put his savings into the stock market to make some money. He decided to follow a " fake guru" (one of those with Facebook Ads saying how easy investing is, how they are rich and successful etc) and went big into the market. After gloves, he went into Serba Dinamik. Ultimately, he loss everything. He is only 35 years old but he said he is at his wits end as he lost everything and is looking to end his life. This prompted me to write this article, in part to address the extremely dark and painful side of the stock market. In addition, is to reach out to others who suffered the same fate of this gentleman. Many retail investors look to the stock market as a path to " get rich quick" . Often they are misled or misrepresented by those who appears on youtube / facebook videos ad " saying how easy it is to quit a day job to be a full time trader." These same bunch of " Gurus" like to use social media to flaunt their wealth whether driving a sports car, wearing a fancy watch or expensive suit. Those who are taken in pays astronomical sum as " fees" to these " fake gurus" . In all honesty, these " fake  Gurus" are very  easy  to spot. This is because in order to prove their " success" , they need to appear " successful" . It is all part of their marketing strategy to lure fresh lambs to slaughter. The worst kind of hypocrites are those who mask themselves as value or fundamental investors when they in fact know nothing about valuation, macroeconomics or reading financial accounts. The are just scam artist and charlatans. In the olden days, they are known snake oil salesman. They move from circle to circle and once the cannot find new " lambs" , they simply work on a new scheme altogether. When things goes bad, they say everyone should be responsible for their own action totally excusing themselves of their liabilities.  If you look at the best value or fundamental investors in the world, they are never showing off or flaunting their wealth. Warren Buffet, Charlie Munger and Peter Lynch are very good example of modesty and humility.  To put it simply, investing in the stock market is not easy at all. It is not for everyone. However, it is ten times more dangerous if someone enters the stock market with a wrong mindset. A wrong mindset would amplify the most heinous desire - greed. It takes you to do things no rational person would. This is why I am so angry when there are prominent investors in our society  telling people to take margin or leverage to invest in the stock market. This is morally reprehensible of the highest order. Those " Fake Gurus" who tell retail investors to " show hand"   or " sailang" is just as bad. Most people who invest in the stock market hopes to make money. But if that is the sole purpose, then one must be prepared to lose everything. If you are not prepared to lose everything, you do not enter the stock market. It is just like being an entrepreneur, if you choose to start your own business, be it big or small, you must be prepared to lose everything as there is always risk when it comes to business. If you are not ready for that, do not be an entrepreneur, be an employee instead. It is both a safer and less emotionally tormenting route.  Hence, investing should always be about using excess funds set aside for the purposes of investing. It should not dip into your savings, children education fund  or monthly commitments.  Personally, I have been tested many times through out my investment journey. I have made countless  mistakes over the years. I have made huge losses especially in the early days. To me, the stock market is where many facets of my existence are constantly being challenged, for example my aptitude, patience, greed, confidence amongst many others. This is also where life lessons can be frequently picked up while it helps me mature not only as an investor but also a person. Until today, I am learning and in order to continue to sustain or to do well, it is a continuous process. Voracious reading is a pre-requisite followed by the need to maintain a strong psychology and healthy  mindset  to weather headwinds. If you are not able to do so, it is best to keep your hard earned money in the Fixed Deposit.  In the beginning of my book, the  Chapter " The Million Dollar Question" , it starts off like this  " Investing is a journey. The passage of time breathes life into this. I have not come across anyone, who can convincingly tell me he or she has mastered the art of investing. Probably, if someone did claim that, it would be a hoax. Most of the successful investors in the world share one common trait - humility" .  With this, I hope all retail investors out there who are passionate with the market do not lose hope when you are losing money in the stock market. Rather, think of where you went wrong, find out your mistakes, learn from it and do better next time. It is a life long journey, I know it for a fact because I am still learning every day. Ps: I want to express my utmost respect to FM988  DJ Chan Fong who have been tirelessly providing counselling and assisting those who went through emotional, traumatic,  mental health issues over the years. Even when I was much younger, before mental health awareness was in focus,  DJ Chan Fong was  already helping many people with his programme. #DJChanFong  -------------------------------------------------------------------------------------------------- For the link to my new book - " Once Upon A Time In Bursa" , please click  HERE  : |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
jarp178
Member |
04-Jul-2021 12:34
|
||||
|
x 0
x 0 Alert Admin |
I think enviro hub is more than just gloves? Understand that they are going to dispose their property and construction business to beef up their financial health and at the same time diversing into healthcare product and not only glove. Should be quite exciting to see things unfold in the next few months? hopefully there are more actions to push the price up further.   
|
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
04-Jul-2021 10:33
|
||||
|
x 0
x 0 Alert Admin |
Maybank says best is over for glove sector as ASP peaks/ 
July 02, 2021 14:25 pm +08 KUALA LUMPUR (July 2): Maybank Investment Bank Bhd (Maybank IB) said today the best is over for the Malaysian rubber glove manufacturing sector as average selling prices (ASPs) had peaked in the first half of 2021 (1H21) amid moderating demand for gloves on rising Covid-19 vaccination rates. Maybank IB analyst Wong Wei Sum wrote in a note today that the glove sector&rsquo s earnings upcycle seems to have been cut short in anticipation of a faster-than-expected decline in glove ASPs in 2H21. " The glove sector is entering a phase of declining ASP (and hence profit) trend on increased supply and rising vaccination rates. Competition is intensifying among both existing and new entrants.  &ldquo ESG (environmental, social, and governance) risk adds further pressure on glove companies&rsquo earnings and valuation outlook. We are switching our valuation method from DCF (discounted cash flow) to PE (price-earnings) multiple, and downgrading the sector to ' neutral' . Hartalega (Holdings Bhd) is our preferred pick,&rdquo she said. Besides Hartalega, Malaysia&rsquo s major rubber glove manufacturers include Top Glove Corp Bhd, Supermax Corp Bhd and Kossan Rubber Industries Bhd. In recent conference calls with analysts, both Hartalega and Top Glove had guided for lower ASPs in the coming months, Wong said today. " Intensifying competition among the existing and new players (especially the rapidly-expanding China glove producers) could further pressure ASP.  " According to a Frost & Sulivan report, ASPs for nitrile/latex gloves are expected to decline by -59%/-52% to US$35 /US$20.40 per 1,000 gloves by 2023, from the current US$85/US$42.70 per 1,000 gloves, respectively,&rdquo Wong said. " We downgrade Kossan (shares) to ' hold' while maintaining our ' buy' (call) on Hartalega and ' hold' (call) on Top Glove,&rdquo Wong said. Maybank IB lowered its Hartalega share target price (TP) to RM9.80 from RM13.10 while Kossan&rsquo s TP was revised down to RM3.20 from RM5.25, according to her. On Top Glove, she said Maybank IB lowered its TP for the stock to RM3.98 from RM4.51. According to Wong, Maybank IB lowered its Hartalega TP to RM9.80 from RM13.10 in tandem with an earnings downgrade on the company for the financial year ending March 31, 2022 (FY22), FY23 and FY24.  " We lower our FY22/FY23/FY24 earnings forecasts for Hartalega by -21%/-19%/-6% after assuming lower blended ASPs for FY22/FY23/FY24 of US$65/US$44/US$29 per 1,000 gloves, while maintaining our earnings forecasts for Kossan and Top Glove as we have already assumed lower ASPs during last results season,&rdquo she said. Meanwhile, TA Securities Holdings Bhd analyst Tan Kong Jin wrote in a note today that based on the current expansion plans of existing glove manufacturers, entry of new players and aggressive glove production capacity expansion by China, TA Securities believes that there is a possibility of glove oversupply in 2022.  " In our forecast, we expect a surplus of 40.3 billion gloves in 2022 (assuming no delays/changes to the targeted expansion plans),&rdquo Tan said. For 2021, he said TA Securities and glove manufacturers, however, project glove supply shortage as the Covid-19 pandemic generates demand for gloves, which is seen as a crucial personal protective equipment. " Based on our channel checks, 2021 capacity will be fully sold. We project a shortage of 27.5 billion gloves while MARGMA (Malaysian Rubber Glove Manufacturers Association) has projected a shortage of 80 billion gloves in 2021.  " We expect future demand for gloves to continue growing by 9% over the next three years on the back of: i) rising hygiene awareness, ii) increasing incidence of chronic communicable diseases, iii) ageing population, iv) wider applications across industries and v) growing usage of gloves,&rdquo he said. Tan said that as Covid-19 vaccination continues to gather pace, daily new cases and deaths linked to the pandemic globally are expected to decrease in the future.  As such, the lead time for gloves has fallen to about 70 days compared to above 250 days at its peak, he said.  Lead time refers to the number of days taken to deliver products to buyers from the day the orders were placed. Hence, Tan said: " We expect (glove) ASP to continue to trend lower and move towards normalisation gradually by end-2023." Overall, glove ASP is still expected to remain above pre-Covid-19 levels due to the increase in cost and structural change in glove usage, according to him. He said the key risk to TA Securities'   glove ASP assumptions is a price war initiated by Chinese players to gain market share. " Following the revision in our earnings forecast and rolling forward our valuations to CY23, we downgrade Big 4&rsquo s (Malaysian glove manufacturers) TP accordingly.  " We maintain our ' buy' recommendation on Hartalega and Kossan with a lower TP of RM10.50 (previously RM12.16) and RM3.98 (previously RM4.90) [respectively].  " We downgrade Top Glove to ' hold' from ' buy' with a lower TP of RM4.02 (previously RM5.30). Meanwhile, we downgrade Supermax to ' sell' from ' buy' with a lower TP of RM2.76 (previously RM6.07). Downgrade rubber glove sector to ' neutral' from ' overweight' ,&rdquo Tan said. These glove manufacturers&rsquo share prices settled lower during Bursa Malaysia&rsquo s 12:30pm break today. Top Glove fell four sen or 0.98% to RM4.03, Hartalega slipped 12 sen or 1.68% to RM7.02, Supermax slid five sen or 1.51% to RM3.26 while Kossan lost eight sen or 2.51% to RM3.11. |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
02-Jul-2021 14:35
|
||||
|
x 0
x 0 Alert Admin |
KLCI at lunch break close 1531. It is very likely investors confidence are continuously eroded daily due to Covid-19 mismanagement by those in power as not only cases are surging but a sudden announcement of EMCO for Selangor and parts of KL took most by surprise. It is never easy to invest in a market when there are policy uncertainties. It affects the visibility of earnings and ordinary course of business which moves the economy.    As can be seen from The Edge article below, foreign funds have been fleeing Southeast Asia due to fears of resurgence in cases. Whether it is temporary or otherwise, the fact remains both local and foreign funds have been net sellers YTD for our local stock market. Unless and until local and foreign funds show net buying pattern, the market will remain in doldrums. Retail investors cannot be the sole buying force in the market. So there are 2 course of action, 1. stay sidelines 2. nibble on fundamentally sound companies with earnings visibility.    Source: www.tradeview.my      https://www.theedgemarkets.com/article/funds-flee-southeast-asia-stocks-vaccine-push-gets-urgent |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
28-Jun-2021 21:37
|
||||
|
x 0
x 0 Alert Admin |
Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study FindsImmune cells are still organizing to fight the coronavirus months after inoculation, scientists reported.June 28, 2021Updated  9:00 a.m. ET
![]() The vaccines made by Pfizer-BioNTech and Moderna  set off a persistent immune reaction in the body  that may protect against the coronavirus for years, scientists reported on Monday. The findings add to growing evidence that most people immunized with the mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much beyond their current forms &mdash which is not guaranteed. People who recovered from Covid-19 before being vaccinated may not need boosters even if the virus does make a significant transformation. &ldquo It&rsquo s a good sign for how durable our immunity is from this vaccine,&rdquo said Ali Ellebedy, an immunologist at Washington University in St. Louis who led the study, which was published in the journal Nature. The study did not consider the coronavirus vaccine made by Johnson & Johnson, but Dr. Ellebedy said he expected the immune response to be less durable than that produced by mRNA vaccines. Dr. Ellebedy and his colleagues reported last month that in people who survived Covid-19, immune cells that recognize the virus  lie quiescent in the bone marrow  for at least eight months after infection. A study by another team indicated that so-called memory B cells continue to mature and strengthen for at least a year after infection. Based on those findings, researchers suggested that immunity might last for years, possibly a lifetime, in people who were infected with the coronavirus and later vaccinated. But it was unclear whether vaccination alone might have a similarly long-lasting effect. Dr. Ellebedy&rsquo s team sought to address that question by looking at the source of memory cells: the lymph nodes, where immune cells train to recognize and fight the virus. After an infection or a vaccination, a specialized structure called the germinal center forms in lymph nodes. This structure is an elite school of sorts for B cells &mdash a boot camp where they become increasingly sophisticated and learn to recognize a diverse set of viral genetic sequences. The broader the range and the longer these cells have to practice, the more likely they are to be able to thwart variants of the virus that may emerge. &ldquo Everyone always focuses on the virus evolving &mdash this is showing that the B cells are doing the same thing,&rdquo said Marion Pepper, an immunologist at the University of Washington in Seattle. &ldquo And it&rsquo s going to be protective against ongoing evolution of the virus, which is really encouraging.&rdquo After infection with the coronavirus, the germinal center forms in the lungs. But after vaccination, the cells&rsquo education takes place in lymph nodes in the armpits, within reach of researchers. Dr. Ellebedy and his colleagues recruited 41 people &mdash including eight with a history of infection with the virus &mdash who were immunized with two doses of the Pfizer-BioNTech vaccine. From 14 of these people, the team extracted samples from the lymph nodes at three, four, five, seven and 15 weeks after the first dose. That painstaking work makes this a &ldquo heroic study,&rdquo said Akiko Iwasaki, an immunologist at Yale. &ldquo This kind of careful time-course analysis in humans is very difficult to do.&rdquo Dr. Ellebedy&rsquo s team found that 15 weeks after the first dose of vaccine, the germinal center was still highly active in all 14 of the participants, and that the number of memory cells that recognized the coronavirus had not declined. &ldquo The fact that the reactions continued for almost four months after vaccination &mdash that&rsquo s a very, very good sign,&rdquo Dr. Ellebedy said. Germinal centers typically peak one to two weeks after immunization, and then wane. &ldquo Usually by four to six weeks, there&rsquo s not much left,&rdquo said Deepta Bhattacharya, an immunologist at the University of Arizona. But germinal centers stimulated by the mRNA vaccines are &ldquo still going, months into it, and not a lot of decline in most people.&rdquo Dr. Bhattacharya noted that most of what scientists know about the persistence of germinal centers is based on animal research. The new study is the first to show what happens in people after vaccination. The results suggest that a vast majority of vaccinated people will be protected over the long term &mdash at least, against the existing coronavirus variants. But older adults, people with weak immune systems and those who take drugs that suppress immunity may need boosters people who survived Covid-19 and were later immunized may never need them at all. Exactly how long the protection from mRNA vaccines will last is hard to predict. In the absence of variants that sidestep immunity, in theory immunity could last a lifetime, experts said. But the virus is clearly evolving. &ldquo Anything that would actually require a booster would be variant-based, not based on waning of immunity,&rdquo Dr. Bhattacharya said. &ldquo I just don&rsquo t see that happening.&rdquo People who were infected with the coronavirus and then immunized see a major boost in their antibody levels, most likely because their memory B cells &mdash which produce antibodies &mdash had many months to evolve before vaccination. The good news: A booster vaccine will probably have the same effect as prior infection in immunized people, Dr. Ellebedy said. &ldquo If you give them another chance to engage, they will have a massive response,&rdquo he said, referring to memory B cells. In terms of bolstering the immune system, vaccination is &ldquo probably better&rdquo than recovering from the actual infection, he said. Other studies have suggested that the repertoire of memory B cells produced after vaccination is more diverse than that generated by infection, suggesting that the vaccines will protect better against variants than natural immunity alone. Dr. Ellebedy said the results also suggested that these signs of persistent immune reaction might be caused by mRNA vaccines alone, as opposed to those made by more traditional means, like Johnson & Johnson&rsquo s. But that is an unfair comparison, because the Johnson & Johnson vaccine is given as a single dose, Dr. Iwasaki said: &ldquo If the J & J had a booster, maybe it will induce this same kind of response.&rdquo |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
tonyja
Elite |
27-Jun-2021 17:02
|
||||
|
x 0
x 0 Alert Admin |
Malaysia' s COVID-19 lockdown to be extended: PM Muhyiddin27 Jun 2021 12:24PM
Asia
Lockdown measures were set to end on Monday. But Muhyiddin said they will not be eased until daily cases fell below 4,000, Bernama said. Malaysia reported 5,803 cases on Saturday. In May, a nationwide movement control order  (MCO) was re-imposed in Malaysia amid a third wave of COVID-19 cases.  Known as MCO 3.0, all economic sectors were allowed to operate during the period but cross-district and interstate travel as well as social, sports and educational activities were prohibited. Stricter restrictions on the economic and social sectors were later announced on May 21 as community cases continued to rise. On Jun 11,  Senior Minister for Defence Ismail Sabri Yaakob  announced in a statement  that the MCO, which was then due to end on Jun 14,  would be extended to Jun 28.   |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
24-Jun-2021 14:11
|
||||
|
x 0
x 0 Alert Admin |
MIDF downgrades glove sector to ' neutral' as peak in urgent demand points to end of supercycle/ 
June 24, 2021 12:32 pm +08 KUALA LUMPUR (June 24): MIDF Research has downgraded glove sector to " neutral" from " positive" , as the upcycle of the sector is coming to a tail end. Its analyst Ng Bei Shan said in a note today the diminishing spot rates and lower average selling prices (ASPs) show that urgent demand has peaked. According to her, compared with the end of 2020, spot ratios for rubber gloves have eased, which means that the urgent orders for rubber gloves may be subsiding. Based on channel checks, she said, glove makers have lower spot allocation compared with one to two quarters ago. " Although we expect prices to stay above pre-pandemic level, we opine that as the urgency for gloves subsides, ASPs for gloves are likely to tilt lower," she said. She also noted that the improving situation of the pandemic in the developed countries has shifted the urgent demand for rubber gloves. The high vaccination rate in the UK, the US and EU would also imply that the urgency for rubber gloves in these countries may slow down and put further pressure on ASPs going forward, she added. Meanwhile, the higher capacity has also contributed to the easing in demand for urgent orders. According to her, this year, companies continued to add in new production lines to churn out more gloves and the estimated new supply, contributed by existing players and new set-ups, expected to increase by more than 30% compared with in the previous year. She also expects glove makers' profit margins to narrow with lower ASPs and firmer cost structure. Adding to the narrower profit margins will be other costs of doing business, which include higher labour costs and the compliance of better environment, social and governance practices, she said. She believes that glove makers' profitability is likely to normalise in tandem with the lower ASPs. On average, she has reduced the sector' s 2022 to 2023 ASP assumption by 5% to 10%. Following the changes in assumptions and earnings estimates, Ng has downgraded Hartalega Holdings Bhd, Kossan Rubber Industries Bhd, Supermax Corp Bhd and Top Glove Corp Bhd to " neutral" from " buy" due to limited upside in capital gain. She has also revised down Hartalega' s target price (TP) to RM8.40 from RM12.96, Kossan' s TP to RM3.31 from RM5.83, Supermax' s to RM3.46 from RM6.73, and Top Glove' s to RM4.55 from RM5.73. " Among the stocks, we prefer Hartalega for its above-industry profitability and its focus on product differentiation and innovation," she said. Hartalega, Top Glove and Supermax were among the top 30 losers this morning. At 11.35am, Hartalega fell 20 sen or 2.5% to RM7.80, Top Glove slipped 11 sen or 2.47% to RM4.34, Supermax slid nine sen or 2.62% to RM3.35. Kossan, meanwhile, shed eight sen or 2.37% to RM3.29. |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
15-Jun-2021 09:20
|
||||
|
x 0
x 0 Alert Admin |
Lack of disclosure by Aspen and Enviro-Hub disadvantaged their minority investors
TWO small Singapore-listed companies trying to make it big in Malaysia' s booming glove-making industry have drawn regulatory scrutiny over the last few weeks - one for announcing a big commercial win prematurely, and the other for disclosing a significant business milestone belatedly.
 
In the latter case, recycling group Enviro-Hub Holdings said on June 7 that its Malaysian associate company Pastel Glove had received " 510 (k)" regulatory clearance from the US Food and Drug Administration (FDA) for its nitrile medical grade examination gloves on May 13.
 
When queried by Singapore Exchange Regulation (SGX RegCo) about the time gap between its announcement and its notification from the US FDA , Enviro-Hub explained that it held back the announcement until it was able to verify that its clearance status was reflected on the FDA database.
 
The company added this was to " avoid prematurely announcing the Section 510(k) clearance and risk announcing misleading information inadvertently" .
 
Enviro-Hub' s cautious approach might seem justifiable after Aspen (Group) Holdings landed in hot water for announcing a major contract win by its glove unit that was subsequently not consummated.
 
Aspen announced on April 13 that it had secured a US$210 million supply deal with Honeywell International. But it retracted that announcement on April 24.
 
Yet, going by what the two companies have said, there is a difference between the two cases.
 
Enviro-Hub had received notification from the US FDA about its 510 (k) status. By contrast, Aspen had not received actual confirmation from Honeywell that the supply deal had been consummated.
 
Aspen said in its retraction announcement that it had executed and delivered what it believed to be the final agreement with Honeywell on April 12, and invoiced Honeywell for the first payment of US$10 million the same day.
 
Aspen understood the " effective date" of the agreement to be April 12, and believed that Honeywell' s execution of the agreement was imminent. Hence, it announced the deal the following day.
 
Whatever the case, the issue at hand is not just about whether Enviro-Hub and Aspen were diligent in ensuring the veracity of their announcements. It is also about the seeming lack of common sense at both companies in making disclosures.
 
Enviro-Hub hikes stake in glove unit
 
On May 18, five days after Enviro-Hub became aware of its 510(k) clearance and decided not to immediately disclose it, the company held an EGM to obtain permission from its shareholders to diversify into healthcare products -- specifically, personal protection equipment like rubber gloves.
 
The resolution received 100 per cent support of shares voted at the EGM.
 
Then, three days later, on May 21, Enviro-Hub announced that it had entered into a term sheet to acquire the 75 per cent of Pastel Glove that it doesn' t already own for S$46.8 million.
 
Enviro-Hub acquired 25 per cent of Malaysia-based Pastel Glove in January through an equity investment of US$0.125 million plus an interest-free shareholder loan of US$4.875 million.
 
The S$46.8 million consideration for the remaining 75 per cent of Pastel Glove will be satisfied by S$23.4 million in cash payments and the issue of 292.5 million new Enviro-Hub shares priced at S$0.08 each.
 
This is a significant transaction. Enviro-Hub has 1.24 billion shares in issue, and a market capitalisation of about S$119 million.
 
Given the imminent EGM and deal to acquire the remaining 75 per cent of Pastel Glove, the 510(k) clearance from the US FDA was a material development, as it would have impacted the market' s perception of Pastel Glove' s value, of which 25 per cent is already owned by Enviro-Hub.
 
Enviro-Hub said on June 7 that " only 20 per cent of the gloves in the market have obtained the 510(k) FDA certification" .
 
The company added that its glove unit will " be able to sell its medical grade nitrile gloves in the US, which typically commands an average selling price of about 10-15 per cent higher than normal gloves due to the limited supply of medical grade gloves in the market" .
 
Clearly, Enviro-Hub should have disclosed the US FDA clearance as soon as it received notification, perhaps with a caveat that it was waiting for its status to be reflected in the FDA database.
 
Without that knowledge, minority shareholders of Enviro-Hub may have been at a disadvantage versus the insiders.
 
Shares in Enviro-Hub closed at S$0.076 on May 12, the day before Enviro-Hub received the US FDA notification. They had climbed to S$0.086 by June 7, when the notification was disclosed.
 
Enviro-Hub closed at S$0.093 yesterday.
 
Aspen' s Honeywell deal called off
 
On the other hand, the problem at Aspen is that the company did not immediately make it clear that the supply deal with Honeywell was dead in the water.
 
On April 24, when it retracted its announcement about the supply agreement, the company merely said that Honeywell had not consummated the deal. It offered no reasons for why this had happened and no explanation of whether this meant the deal was off or merely delayed.
 
On April 29, in its response to queries from SGX RegCo, Aspen revealed that it became aware that the deal had not been consummated on April 14. Aspen said it did not immediately announce this because it first needed to clarify the reasons for the non-consummation of the deal.
 
Yet, Aspen still did not reveal these reasons. Instead, the company stated the agreement was not subject to any " express conditions precedent" , and that Honeywell had submitted Aspen' s initial invoice for processing.
 
As this column noted two weeks ago, this created the impression the ball was in Honeywell' s court.
 
It was only after a second round of queries from SGX RegCo that Aspen finally came clean. On June 4, responding to those queries, Aspen said discussions with Honeywell about the supply deal had been called off.
 
Aspen said it did not announce this earlier because it had wanted to engage Honeywell in another discussion after a " cooling-off period" .
 
Minority investors of Aspen were clearly put at a disadvantage by the company not immediately disclosing that supply deal had been called off.
 
Shares in Aspen closed at S$0.265 on April 9, before trading was halted for the announcement of the Honeywell supply deal. The stock closed at S$0.205 on June 4, just before Aspen finally stated explicitly that the deal was off.
 
Aspen closed at S$0.183 yesterday.
 
SGX RegCo should closely examine the recent announcements by Aspen and Enviro-Hub and determine if the two companies have properly observed their continuous disclosure obligations.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Boscoyes
Member |
13-Jun-2021 19:14
|
||||
|
x 0
x 0 Alert Admin |
This counter is like that...fast fast up then pull back..then slowly slowly quietly up bit by bit lor...
|
||||
| Useful To Me Not Useful To Me | |||||
|
ysh2006
Supreme |
13-Jun-2021 18:43
|
||||
|
x 0
x 0 Alert Admin |
Only one day in the morning last Tue ...pull back fast too!!... | ||||
| Useful To Me Not Useful To Me | |||||
|
Boscoyes
Member |
13-Jun-2021 18:03
|
||||
|
x 0
x 0 Alert Admin |
No need wait, all can fry together😏
|
||||
| Useful To Me Not Useful To Me | |||||
|
ysh2006
Supreme |
12-Jun-2021 16:00
|
||||
|
x 0
x 0 Alert Admin |
After RH Petrol and CFM, hope BB will come back to fry it up again....
|
||||
| Useful To Me Not Useful To Me | |||||
|
JustDuit
Member |
10-Jun-2021 09:01
|
||||
|
x 0
x 0 Alert Admin |
With the new normal, gloves will be more commonly used. Should significantly increase share price.
|
||||
| Useful To Me Not Useful To Me | |||||


.jpg)

